by Barry T. Katzen MD
An explosion in non-invasive imaging of the heart will lead to significant changes in practice patterns in coming years and the need to forge new cooperative relationships.
MR angiography (MRA) has matured into an extremely reliable,
accurate, and valuable diagnostic vascular tool. Accurate imaging
of excellent quality, using MRA for both cardiac and noncardiac
applications, is now available in many medical centers equipped
with state-of-the-art, high-performance gradients and fast pulse
sequences.
This has led to a virtual explosion of research and application
development in the field of MRA, the fruits of which we and our
patients are beginning to enjoy today. One can now successfully
acquire diagnostic angiograms of all major vascular territories
with MRA replacing conventional angiography. In coronary
applications, promising work is being done for the visualization of
coronary arteries with and without using contrast injections.
These clinical applications encompass the lion's share of
traditional invasive angiography as experienced in a busy vascular
suite. MRA is inexpensive relative to invasive angiography, is
almost risk free, and uses no ionizing radiation or nephrotoxic
contrast. In addition, MRA results can be rendered as a
three-dimensional volume, allowing visualization of the vasculature
in any obliquity with a single acquisition of data. Areas of
research and development that have produced methods nearing
clinical approval include faster imaging sequences and blood-pool
agents for arterial and venous applications. Real-time MRI is
already available; with further refinement, it will allow for a
true real-time fluoroscopic evaluation of the vasculature by
tracking small boluses of contrast through the body. MRI-guided
endovascular interventions will be a clinical reality soon (once
MRI-compatible catheters and balloons are approved for use in the
noncoronary circulation). Application of interventional techniques
to the coronary circulation will take longer, but its impact on the
diagnosis of coronary disease will be significant. Plaque
characterization and assessment of stability will be possible using
dedicated intravascular coils and catheters. At the same time,
cardiac applications are developing at a rapid paceand so is the
technology, in order to keep up with the demands of physicians. The
provocative concept of a single cardiovascular screening
examination, a one-stop cardiovascular assessment performed in 30
to 40 minutes is rapidly becoming a reality (and has, in fact, been
demonstrated in some centers in Europe). It is therefore possible,
using a single noninvasive modality, to provide imaging of cardiac
anatomy, function, and perfusion; coronary-artery anatomy; and the
entire peripheral vascular circulation, all in one examination!
This paradigm shift, which is only beginning, has significant
clinical and financial ramifications, since MRA is safer, cheaper,
and far more convenient for our patients than invasive
angiography.
What might this mean to vascular interventionalists and
interventional cardiologists? Cardiovascular MRI will continue to
become a critical point of entry into the health care system for
many patients with cardiovascular disease. Those physicians who
participate stand to be the beneficiaries of the potential
interventions that follow, analogous to the pattern now seen for
noninvasive vascular laboratories, echocardiography, and stress
testing. The dissemination and accessibility of health information
will continue to empower patients, as well as their physicians, to
rightfully resist an invasive study and demand the safer, more
comprehensive, convenient, and elegant alternative cardiovascular
work-up.
Even today, we have the obligation to inform our patients about
MRA as an excellent alternative prior to obtaining consent for
invasive diagnostic studies in the periphery. Soon, a similar
necessity may arise for coronary angiography. In addition, the
quality of MRA has developed to the point that it should no longer
be reserved for patients who have renal insufficiency. MRA could be
used as a primary imaging modality in any patients who do not have
absolute contraindications for MRI examinations. For cardiac
applications, MRI and MRA already have great value for assessing
cardiac chambers and function, congenital heart abnormalities, flow
dynamics, myocardial function, and coronary-artery anatomy, with
rapid advances being made in all areas.
For those of us performing invasive procedures, particularly in
the periphery but also in the coronary circulation, the shift away
from the need for invasive diagnostic angiography will have a
significant effect. In addition to MRA, CT angiography,
particularly for coronary artery circulation, offers the
opportunity to obtain highly detailed images of the coronary
arterial tree. While still requiring ionizing radiation and
contrast, fast multidetector and other fast CT examinations offer
the potential to visualize the coronary arterial tree in great
detail. Clearly, the future direction of diagnostic angiography is
one of diminished need for invasive angiography for cardiac,
coronary, and peripheral angiography.
Anticipating the resulting shift in workload and, particularly,
technological shifts that may have an impact on practice patterns
is extremely important to the stability of provider organizations.
One of the advantages of the multidisciplinary collaboration
present at Miami Cardiac & Vascular Institute is the need for
us to anticipate the future and to begin developing plans for
dealing with the effects of technology shifts on practice patterns.
If diagnostic angiography is eliminated and replaced by an imaging
modality that is totally noninvasive and can be performed by staff
from a variety of disciplines, how does this affect interventional
cardiologists? Similarly, if all diagnostic angiography of the
peripheral circulation were to disappear, what would be the effect
on invasive radiologists and those in other disciplines involved in
peripheral vascular intervention?
These questions may seem, to some, irrelevant at this time, but
the future will bring the need for this discussion. Therefore, at
Miami Cardiac & Vascular Institute, we have begun to consider
some of these issues (and, in particular, to develop collaborative
efforts to optimize both technology and image-interpretation
quality). Avoiding major work shifts and involving disciplines from
different specialties generally has the effect of increasing
overall volume and allowing the participation of a diverse group of
people.
The impact of less invasive imaging on invasive imaging is going
to be significant over the next several years. Both MRI and fast CT
applications will greatly reduce the need for diagnostic invasive
angiography for both cardiac and peripheral circulations. Since
this is an area of interest to both radiology and cardiology, now
is the time to consider and develop good working relationships
between the disciplines whose members have a primary interest in
the imaging of the cardiovascular system. Clearly, for
cardiologists who are interested in participating in MRI, dedicated
training will be required, especially if dedicated cardiovascular
magnets are developed and implemented. In large cardiovascular
centers, it may make sense to begin looking at installing dedicated
magnets for cardiovascular diagnosis and placing them within the
interventional environment, directly adjacent to angiography
suites. This has been implemented at the Miami Cardiac &
Vascular Institute already and has promoted integration of
technology and physicians.
The future of noninvasive imaging is bright, and the need for
invasive techniques to image the heart and circulatory tree will
diminish. Experience in several centers has already demonstrated
that the increasing use of noninvasive techniques can result in a
significant increase in intervention, and we anticipate that this
will happen. The current role of the diagnostic vascular specialist
should be reassessed, and perhaps additional training should be
obtained to ensure that the use of a noninvasive imaging modality
is woven into the mainstream of cardiovascular diagnosis.
Barry T. Katzen, MD
Medical Director
Miami Cardiac & Vascular Institute